Harvard Law School Professor Glenn Cohen, faculty director of the Petrie-Flom Center for Health Law Policy, Biotechnology and Bioethics, recently co-authored an article with Harvard Medical School Dean George Q. Daley and Eli Y. Adashi, professor of medical science and former dean of medicine and biological sciences at Brown University, for the journal Science Translational Medicine on the emerging and experimental treatment known as in vitro gametogenesis (IVG).
During the fall 2016 semester, a group of leading scholars came together at Harvard Law School for the lecture series, “Diversity and US Legal History,” which was sponsored by Dean Martha Minow and organized by Professor Mark Tushnet, who also designed a reading group to complement the lectures.
The Football Players Health Study at Harvard University today released a set of legal and ethical recommendations to address a series of structural factors that affect NFL player health. The Football Players Health Study is a research initiative composed of several ongoing studies examining the health and wellbeing of NFL players.
Professor Glenn Cohen breaks down complex topic for Ed Portal and online audience.
The Coalition to Transform Advanced Care (C-TAC), a non-profit organization with a vision of improving advanced illness care for all Americans, and the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School co-hosted the inaugural event for their new collaboration: The Project on Advanced Care and Health Policy.
Harvard Law School Professor I. Glenn Cohen, faculty director of the School’s Petrie-Flom Center for Health Law Policy, Biotechnology & Bioethics spoke with the Harvard Gazette about Monday’s ruling by the Supreme Court that overturned a Texas law requiring that abortion clinics maintain hospital-like standards at their facilities as well as admitting privileges at local hospitals.
“FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies,” edited by Holly Fernandez Lynch and I. Glenn Cohen ’03 (Columbia). Stemming from a 2013 conference at HLS, the book features essays covering major developments that have changed how the FDA regulates; how the agency encourages transparency; First Amendment issues; access to drugs; and evolving issues in drug-safety communication. These issues, the editors write, lie “at the heart of our health and health care.”
On March 29, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School celebrated its first decade and kicked off the next with a conference that focused on the future of health law and policy.
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and the Coalition to Transform Advanced Care (C-TAC) today announced a new collaboration, The Project on Advanced Care and Health Policy.
In a visit to Harvard Law School on Jan. 20, former U.S. Food and Drug Administration commissioner Dr. Margaret A. Hamburg HMS ’83 reflected on her six-year tenure at the agency and shared her thoughts about the future of public health regulation.